dapagliflozin
NDA- Indications
- Diabetes
Company intelligence / Profile preview
Beijing Science Sun Pharmaceutical is a publicly traded Chinese biopharma company focused on research, development, production, and sales of biological drugs including active proteases, polypeptides, polysaccharides, amphoteric lipids. Its marketed portfolio covers cardiovascular/cerebrovascular/immune/nervous system indications. The company also develops monoclonal/bispecific antibody therapeutics and vaccines with several candidates advancing through clinical trials—most notably LZ901 herpes zoster vaccine which showed high immunogenicity/safety in Phase I/II studies. It operates manufacturing/R&D facilities in Beijing and Zhuhai.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Science Sun Pharmaceutical Co., Ltd..